Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 15 → 16·14:21, 4 Dec 2025
Difference between revision 15 and revision 16 of Qingdao Saber Technology Pharmaceutical. 14 lines changed; the page grew by 1,609 bytes.
| Revision 15 — 05:47, 20 Nov 2025 CiteBot (talk) bot: sort category members 10,522 bytes +1,387 | Revision 16 — 14:21, 4 Dec 2025 ArchiveBot (talk) bot: update parent category chain 12,131 bytes +1,609 | ||
|---|---|---|---|
| 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. | 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. |
| 72 | 72 | ||
| + | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | |
| + | 74 | ||
| 73 | == Reception == | 75 | == Reception == |
| 74 | The PeptidePedia tally records 668 self-reported submissions to July 2026. Recurring themes are dispatch speed from held stock and the handling of pre-order technical questions.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | 76 | The PeptidePedia tally records 668 self-reported submissions to July 2026. Recurring themes are dispatch speed from held stock and the handling of pre-order technical questions.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} |
| ⋮ | ⋮ | ||
| 81 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | 83 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} |
| 82 | 84 | ||
| + | 85 | PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} | |
| + | 86 | ||
| + | 87 | == Regulatory position and legal status == | |
| + | 88 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | |
| + | 89 | ||
| + | 90 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | |
| + | 91 | ||
| 83 | == References == | 92 | == References == |
| 84 | {{reflist}} | 93 | {{reflist}} |
| ⋮ | ⋮ | ||
| 91 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 100 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| 92 | 101 | ||
| + | 102 | == Further reading == | |
| + | 103 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 104 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 105 | ||
| 93 | == See also == | 106 | == See also == |
| 94 | * [[Certificate of analysis]] | 107 | * [[Certificate of analysis]] |
| ⋮ | ⋮ | ||
| 98 | * [[Research use only]] | 111 | * [[Research use only]] |
| 99 | * [[Peptide supply chain]] | 112 | * [[Peptide supply chain]] |
| + | 113 | * [[Blind sampling]] | |
| 100 | 114 | ||
| 101 | {{DEFAULTSORT:Qingdao Saber Technology Pharmaceutical}} | 115 | {{DEFAULTSORT:Qingdao Saber Technology Pharmaceutical}} |